CLINICAL EVALUATION OF KANTAKARYAVALEHA AND ELADI GUTIKA IN THE MANAGEMENT OF MILD STABLE BRONCHIAL ASTHMA (TAMAKA SHWASA)

Central Council for Research in Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients of either sex with age between 18 to 60 years.
•2. Diagnosed cases of the mild predominant or persistent stable Bronchial Asthma (Tamaka
•Shwasa) (as per GINA Guideline)
•3. FEV1 >80% of the predicted value
•4. Patients willing to participate and written consent

•1. Patients with FEV1 < 80% of the predicted value.
•2. Patients with Diabetes Mellitus, Chronic Obstructive Pulmonary Disorder (COPD),
•Cardio vascular diseases, malignancy etc.
•3. Patients with unstable Cardiovascular disease
•4. Patients suffering from other major systemic illness which may influence the study as per
•5. Patients with LFT, Aspartate Amino Transferase (AST) and / or Alanine Amino
•Transferase (ALT) > 2 times upper normal limit or Serum Creatinine more than the upper
•limit of normal value.
•6. Pregnancy or lactating women.

发起方